Canada Pulls Controversial Pricing Measures
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
You may also be interested in...
Provisional guidance on controversial pricing reforms is now in place in Canada.
Changes to Canada’s reference pricing system kick in on 1 July and could save billions.
This month, long-awaited new pricing measures in Canada will come into force, while several trials will either kick off or end, including a liability opioids case involving Teva in San Francisco and Hatch-Waxman litigation over Otsuka/Lundbeck’s Rexulti.